According to Immuno-Biological Laboratories latest financial reports the cash on hand of 4570 is $4.31M, an increase of 20.82% to 2022. At the end of 2022 company had $3.56M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $4.31M | 20.82% |
2022 | $3.56M | -15.86% |
2021 | $4.24M | -41.55% |
2020 | $7.25M | -33.05% |
2019 | $10.82M | - |